Core Viewpoint - Agilent Technologies reported a strong financial performance for Q4 2025, with revenue of $1.86 billion, a year-over-year increase of 9.4%, and an annual revenue of $6.95 billion, growing by 6.7%. The company expects revenue for 2026 to be between $7.3 billion and $7.4 billion, reflecting a growth of 5% to 7% [1][3][6]. Financial Performance Summary - Q4 2025 revenue reached $1.86 billion, exceeding expectations, with a core growth of 7.2% [4]. - The net profit under GAAP for Q4 was $434 million, with an EPS of $1.53, marking a 25% increase from Q4 2024 [4][7]. - For the entire fiscal year 2025, revenue was $6.95 billion, surpassing expectations, with a reported growth of 6.7% and a core growth of 4.9% [6]. Quarterly Performance Breakdown - Q1 2025: Revenue of $1.68 billion, a 1.4% increase, with LDG business growth of 4% [5]. - Q2 2025: Revenue of $1.67 billion, a 6.0% increase, with a 10% growth in China [5]. - Q3 2025: Revenue of $1.74 billion, with a core growth of 10.1% [5]. - Q4 2025: Revenue of $1.86 billion, a 9.4% increase, with annual revenue exceeding expectations [5]. Business Segment Performance - Life Sciences and Diagnostics Group (LDG) reported Q4 revenue of $755 million, a 15% increase, with a core growth of 11% [10]. - Agilent CrossLab Group (ACG) had Q4 revenue of $755 million, a 7% increase, with a customer satisfaction rate exceeding 90% [11]. - Application Markets Group (AMG) reported Q4 revenue of $351 million, a 4% increase, facing some challenges but showing stability in environmental and food safety sectors [12]. Outlook for 2026 - The company is optimistic about 2026, expecting revenue between $7.3 billion and $7.4 billion, with a core growth of 4% to 6% [13]. - For Q1 2026, revenue is projected to be between $1.79 billion and $1.82 billion, reflecting a year-over-year growth of 6% to 8% [13].